rs79736124
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006158.5(NEFL):c.*1100C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0384 in 152,618 control chromosomes in the GnomAD database, including 155 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 155 hom., cov: 32)
Exomes 𝑓: 0.079 ( 0 hom. )
Consequence
NEFL
NM_006158.5 3_prime_UTR
NM_006158.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.43
Genes affected
NEFL (HGNC:7739): (neurofilament light chain) Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 8-24951710-G-A is Benign according to our data. Variant chr8-24951710-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 362628.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-24951710-G-A is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest population allele frequency = 0.0787 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0383 AC: 5821AN: 152068Hom.: 155 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5821
AN:
152068
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0787 AC: 34AN: 432Hom.: 0 Cov.: 0 AF XY: 0.0885 AC XY: 23AN XY: 260 show subpopulations
GnomAD4 exome
AF:
AC:
34
AN:
432
Hom.:
Cov.:
0
AF XY:
AC XY:
23
AN XY:
260
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
34
AN:
426
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
2
Other (OTH)
AF:
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0383 AC: 5824AN: 152186Hom.: 155 Cov.: 32 AF XY: 0.0392 AC XY: 2918AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
5824
AN:
152186
Hom.:
Cov.:
32
AF XY:
AC XY:
2918
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
983
AN:
41526
American (AMR)
AF:
AC:
559
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
196
AN:
3466
East Asian (EAS)
AF:
AC:
2
AN:
5178
South Asian (SAS)
AF:
AC:
46
AN:
4820
European-Finnish (FIN)
AF:
AC:
1021
AN:
10582
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2792
AN:
68008
Other (OTH)
AF:
AC:
113
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
290
580
871
1161
1451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Charcot-Marie-Tooth disease, type I Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.